Drugs / Vobarilizumab
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02101073 | Mar → Jul 2014 | rheumatoid arthritis | Ablynx, a Sanofi company | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01284569 | Mar 2011 → Sep 2012 | rheumatoid arthritis | Ablynx, a Sanofi company | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT02437890 | Jul 2015 → Jan 2018 | systemic lupus erythematosus | Ablynx, a Sanofi company | Completed | No outcome recorded |
| Phase 2 | NCT02518620 | Jul 2015 → Aug 2018 | rheumatoid arthritis | Ablynx, a Sanofi company | Completed | No outcome recorded |
| Phase 2 | NCT02287922 | Mar 2015 → Jul 2016 | rheumatoid arthritis | Ablynx, a Sanofi company | Completed | No outcome recorded |
| Phase 2 | NCT02309359 | Jan 2015 → Aug 2016 | rheumatoid arthritis | Ablynx, a Sanofi company | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2013-09-23 | AbbVie | Ablynx And AbbVie Sign Global License Agreement For anti-IL-6R Nanobody, ALX-0061, To Treat Inflammatory Diseases abbvie.com ↗ |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vobarilizumab | “Vobarilizumab (ALX-0061) and placebo were supplied as a sterile liquid for s.c. injection at a volume of 0.5 mL and 1.0 mL in pre-filled single-use syringes.” NCT02437890 ↗ |
| Known as | ALX-0061 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01284569 ↗ |
| Modality | Protein / enzyme biologic | “ALX-0061, a Nanobody targeting the receptor for interleukin 6 (IL6R)” NCT01284569 ↗ |
| Route | Intravenous | “Intravenous administration” NCT01284569 ↗ |
| Target | IL6R | “Nanobody targeting the receptor for interleukin 6 (IL6R)” NCT01284569 ↗ |